top of page
Home
About
All News
Contact
Advertise
Members
More
Use tab to navigate through the menu items.
Search
Rx News
News & Latest Updates
Log In
All Posts
Guidelines
Clinical Trials
Patient Stories & PEL
Case Reports
New Approvals
Spotlight
Cardiovascular outcomes with Semaglutide in high-risk patients
Oral Semaglutide was approved by the FDA in September 2019 to improve blood glucose control in adult patients with type 2 diabetes (1). ...
Ms. Roma Joglekar
Sep 9
2 min read
Back to Top
bottom of page
